Skip to content
DataLookout
Menu

NCT07942805

Dexamethasone Doses and Glycemic Response in Diabetic Cholecystectomy

StatusNot Yet Recruiting
PhasePhase 4
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Maximum Perioperative Blood Glucose Concentration
Timeframe: At 24 hours

Secondary (7)

Time to Peak Blood Glucose Concentration
Proportion of Patients Developing Hyperglycemia
Proportion of Patients Developing Severe Hyperglycemia
Requirement for Rescue Insulin
Incidence of Hypoglycemia
Show 2 moreShow less
Postoperative Nausea and Vomiting
Surgical Site Infection

Arms and interventions

4 mg DexamethasoneExperimental

Patients will receive 4 mg of intravenous dexamethasone diluted in 0.9% normal saline to 5 mL, administered intravenously over 30 seconds.

8 mg DexamethasoneExperimental

Patients will receive 8 mg of intravenous dexamethasone diluted in 0.9% normal saline to 5 mL, administered intravenously over 30 seconds.

PlaceboPlacebo comparator

Patients will receive an equivalent volume of 0.9% normal saline intravenously as placebo.

Drugs: Dexamethasone 4mg, Dexamethasone 8 mg, Placebo (0.9% Normal Saline)